Mesoporous Silica Nanoparticles With Customized Drug Ratio/Loading for Effective Treatment of Gemcitabine-Resistant Pancreatic Tumors.

Adv Nanobiomed Res · 2026 · PMC13179672 · PMID 42145464

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In the case of GR-BxPC3 cells, Western blotting indicates an increase in Vimentin, and a decreasing trend in both N- and E-cadherin as compared to C-BxPC3 ( Figures 2H and S1 ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.